Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Vincristine and Irinotecan With or Without Temozolomide in Children and Adults With Refractory or Relapsed Rhabdomyosarcoma : International Randomized Trial (VIT-0910)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified June 2014 by Centre Oscar Lambret.
Recruitment status was:  Active, not recruiting
Sponsor:
Collaborator:
SFCE
Information provided by (Responsible Party):
Centre Oscar Lambret
ClinicalTrials.gov Identifier:
NCT01355445
First received: May 16, 2011
Last updated: June 20, 2014
Last verified: June 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: June 2015
  Estimated Primary Completion Date: June 2014 (Final data collection date for primary outcome measure)